Niagen Bioscience Inc
- NAGE
- NASDAQ
- Biotechnology
- Anti-Aging/NAD+ Research
- Nicotinamide Riboside (Niagen)
$2.50
Today +0.40%Quote Oct 19, 2026, 08:00 PM UTC
−16.72%over the last month
Max drawdown −19.4%From 1-month high −19.4%3 months −26.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Niagen Bioscience
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
117
Founded
1999
Market value
$197.8M
Quote Oct 19
Floor
$2.42
3.1% below price
Resistance
$2.52
0.7% above price
Price vs analyst targets
5 analysts
Lowest target
$10.00Highest target
$11.00
$10.00Highest target
$11.00
- Price $2.50
- Average target $10.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 313% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NAGEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free